Patients with COVID-19 who have underlying chronic lung disease are at increased risk for developing severe illness. Pulmonologist Brian Southern, MD, recently authored a review article in Cleveland Clinic Journal of Medicine’s COVID-19 Curbside Consults series. In this article, he takes a closer look at what is known about ILD and sarcoidosis in the context of the pandemic and offers insights for managing care.
Mild symptoms and a quick recovery are common in most cases of sarcoidosis, but a minority of patients have significant morbidity and impaired quality of life because of multiorgan involvement. A new Cleveland Clinic study examines association between income and sarcoidosis outcomes, after controlling for socioeconomic and disease-related factors.
A list of recommendations on where we should target future research efforts in treatment-resistant pulmonary sarcoidosis.
A study of 2773 patients found that male gender, lower self-reported income, older age and longer disease duration independently predicted increased hospitalization rates in patients with sarcoidosis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A Cleveland Clinic expert guides ATS 2018 attendees through the diagnosis and management of two challenging manifestations of sarcoidosis: neurologic and cardiac sarcoidosis.
A highly unusual case of severe Candida pneumonia, in which the diagnosis was supported by microbiologic cultures, molecular studies and histologic evidence from lung biopsies.
Symptomatic cardiac involvement in systemic sarcoidosis occurs in only 2 to 5 percent of patients. The most common manifestations include atrioventricular block, ventricular arrhythmia and heart failure. Experts in the field discuss screening, diagnosis, medical therapy, device/ablation therapy and prognosis.